For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.
Faculty: Debbie Shawcross (Moderator), Rajiv Jalan (Faculty), Vish Patel (Faculty), Jonel Trebicka (Faculty)
This EASL Studio is supported by Alfasigma. EASL has received no input from Alfasigma with regards to the content of this programme.